Torthaí cuardaigh - Sutton, Kenneth C

Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study de réir Sutton, Kenneth C, De Vente, Jerome, Leblanc, Roger, Dejesus, Edwin, Smith, Graham, Mills, Anthony, Baril, Jean-Guy, St. Clair, Marty, Stancil, Britt S, Vandermeulen, Kati, Spreen, William R

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Long-acting cabotegravir and rilpivirine for HIV-1 suppression: switch to 2-monthly dosing after 5 years of daily oral therapy de réir Mills, Anthony, Richmond, Gary J., Newman, Cheryl, Osiyemi, Olayemi, Cade, Jerry, Brinson, Cynthia, De Vente, Jerome, Margolis, David A., Sutton, Kenneth C., Wilches, Viviana, Hatch, Sarah, Roberts, Jeremy, McCoig, Cynthia, Garris, Cindy, Vandermeulen, Kati, Spreen, William R.

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán

Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study de réir Smith, Graham H R, Henry, W Keith, Podzamczer, Daniel, Masiá, Maria Del Mar, Bettacchi, Christopher J, Arasteh, Keikawus, Jaeger, Hans, Khuong-Josses, Marie-Aude, Montes-Ramírez, Maria Luisa, Stellbrink, Hans-Jürgen, Yazdanpanah, Yazdan, Richmond, Gary J, Sutton, Kenneth C, Zhang, Feifan, McCoig, Cynthia C, St Clair, Marty H, Vandermeulen, Kati, Van Solingen-Ristea, Rodica, Smith, Kimberly Y, Margolis, David A, Spreen, William R

Faigh an téacs iomlán Faigh an téacs iomlán Faigh an téacs iomlán